Searchable abstracts of presentations at key conferences in endocrinology

ea0005p65 | Clinical Case Reports | BES2003

Empty sella presenting as a syndrome of inappropriate antidiuretic hormone secretion

Helmy A

An 85 year old woman presented with generalised fatigue.Clinical examination was unremarkable but her biochemistry showed low sodium level of 112 millimoles per litre ( NR : 135-145 ).Investigations were suggestive of Syndrome of Inappropriate Antidiuretic Hormone Secretion ( SIADH ) with low serum osmolality , high urine osmolality and high urinary sodium .Further investigations were normal including renal function , short synacthen test , chest x-ray and CT scan of t...

ea0028p383 | Thyroid | SFEBES2012

A case of hyperthyroidism presenting with cholestasis

Helmy Ahmed , Boules Evon

An 85 year old lady was admitted with painless jaundice and cholestatic liver functions (LFTs). Investigations organised by gastroenterologists were fine including hepatitis viral screen, copper and ceruloplasmin levels, alpha -one antitrypsin, alpha -fetoprotein, immunoglobulins, auto-immune screen and ultrasound scan of the liver. In view of palpitations and weight loss, thyroid functions (TFTs) were done and showed biochemical hyperthyroidism: FT4 of 36.8 pmol/L (12–22...

ea0025p332 | Thyroid | SFEBES2011

A case of amiodarone induced thyrotoxicosis, type II followed by subsequent hypothyroidism

McElwaine Fred , Helmy Ahmed

Introduction: Amiodarone is a class III antiarrhythmic agent widely used in the treatment of atrial and ventricular arrhythmias.Amiodarone is known to cause thyroid dysfunction in three ways; amiodarone induced hypothyroidism, amiodarone induced thyrotoxicosis (AIT) type I and type II.We present a case of a patient with AIT type II who subsequently developed hypothyroidism.Case presentation: A 43-year-old man...

ea0015p381 | Thyroid | SFEBES2008

Case report: type 3 amiodarone induced thyrotoxicosis

Helmy Ahmed , Nugent Ailish

A 48-year-old gentleman was referred to the endocrine team with abnormal thyroid function tests (TFTs). His background history included cardiomyopathy complicated by atrial fibrillation (AF). He had been treated with amiodarone for a year. TFTs were monitored regularly during treatment and were normal. Four months after stopping amiodarone, he complained of weight loss, sweating and tremor. He had no family history of thyroid disease. He had a resting heart rate of 120/min (AF...

ea0009p178 | Thyroid | BES2005

Dietary factors in Thyrotoxicosis management: case report on excessive ‘Brassica’ intake

Helmy A , Soo S

A 76 year old woman was referred in December 1997 to the Endocrine clinic at Luton & Dunstable Hospital following admission with atrial fibrillation which was managed by digoxin, flecainide and warfarin.Investigations initiated by her GP included reduced TSH at 0.18 milliUnits/Litre (0.32-5.00) despite normal free T4 of 14 picomols/Litre (9-24) and normal free T3 of 4.4 picomols/Litre (2.5-5.3). Ultrasound scan was in favour of multinodular goitre an...

ea0053p07 | (1) | OU2018

The use of ketogenic diet in a patient with post-prandial hyperinsulinemic hypoglycaemia after m Roux-en-Y Gastric Bypass surgery: a case study

Abbott Sally , Dindol Naomi , Singhal Rishi , Helmy Ahmed , Ahmed Mohamed , Bellary Sri , Tahrani Abd

Background: Hyperinsulinemic hypoglycaemia (HH) after Roux-en-Y gastric bypass (RYGB) is rare. Patients typically present with post-prandial hypoglycaemia >1 year after surgery and once weight loss has plateaued. Despite multiple treatment options, the management of these patients remains challenging.Clinical case: A 31-year-old female was referred for bariatric surgery with a BMI of 41.4 kg/m2. In the year preceding the r...

ea0099ep3 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Atherosclerotic cardiovascular disease and its risk factors in type 2 diabetes in egypt: insights from PACT-MEA study and implications for interventions

Assaad-Khalil Samir , Bassyouni Atef , Toaima Dalia , Sotouhy Gawish Hanan , El Hefnawy Hesham , Helmy Megallaa Magdy , Abushady Manal , ElKafrawy Nabil , Seddik Hosny Salwa , Mohamed Massoud Tarek

Background: Atherosclerotic cardiovascular disease (ASCVD) is a major complication to type 2 diabetes (T2D), in terms of both severity and prevalence rates. The Prevalence and clinical management of the Atherosclerotic Cardiovascular Diseases in patients with Type 2 Diabetes across Middle East and Africa countries (PACT-MEA) is a multinational study that aimed to investigate the prevalence of both established ASCVD and the risk for ASCVD in people with T2D as well as its clini...